Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

NCT01794520 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: Venetoclax
DRUG: Dexamethasone

Sponsor

AbbVie

Collaborators

[object Object]